General MedicationsOPHTHALMICStandard
MIEBO
PERFLUOROHEXYLOCTANE
Standard Dose
1.338GM/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MIEBO is listed in Drugs@FDA under application 216675 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PERFLUOROHEXYLOCTANE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1.338GM/ML Sponsor BAUSCH AND LOMB INC Submission history Latest submission status date: 2025-10-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview MIEBO is listed in Drugs@FDA under application 216675 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PERFLUOROHEXYLOCTANE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1.338GM/ML Sponsor BAUSCH AND LOMB INC Submission history Latest submission status date: 2025-10-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.